CKAP4_HUMAN - dbPTM
CKAP4_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CKAP4_HUMAN
UniProt AC Q07065
Protein Name Cytoskeleton-associated protein 4
Gene Name CKAP4
Organism Homo sapiens (Human).
Sequence Length 602
Subcellular Localization Endoplasmic reticulum membrane
Single-pass type II membrane protein. Cell membrane
Single-pass type II membrane protein. Cytoplasm, cytoskeleton. Cytoplasm, perinuclear region. Translocates to the perinuclear region upon APF-stimulation.
Protein Description High-affinity epithelial cell surface receptor for APF.; Mediates the anchoring of the endoplasmic reticulum to microtubules..
Protein Sequence MPSAKQRGSKGGHGAASPSEKGAHPSGGADDVAKKPPPAPQQPPPPPAPHPQQHPQQHPQNQAHGKGGHRGGGGGGGKSSSSSSASAAAAAAAASSSASCSRRLGRALNFLFYLALVAAAAFSGWCVHHVLEEVQQVRRSHQDFSRQREELGQGLQGVEQKVQSLQATFGTFESILRSSQHKQDLTEKAVKQGESEVSRISEVLQKLQNEILKDLSDGIHVVKDARERDFTSLENTVEERLTELTKSINDNIAIFTEVQKRSQKEINDMKAKVASLEESEGNKQDLKALKEAVKEIQTSAKSREWDMEALRSTLQTMESDIYTEVRELVSLKQEQQAFKEAADTERLALQALTEKLLRSEESVSRLPEEIRRLEEELRQLKSDSHGPKEDGGFRHSEAFEALQQKSQGLDSRLQHVEDGVLSMQVASARQTESLESLLSKSQEHEQRLAALQGRLEGLGSSEADQDGLASTVRSLGETQLVLYGDVEELKRSVGELPSTVESLQKVQEQVHTLLSQDQAQAARLPPQDFLDRLSSLDNLKASVSQVEADLKMLRTAVDSLVAYSVKIETNENNLESAKGLLDDLRNDLDRLFVKVEKIHEKV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Phosphorylation-----MPSAKQRGSK
-----CCCHHHCCCC
46.9622536245
9PhosphorylationPSAKQRGSKGGHGAA
CCHHHCCCCCCCCCC
30.2524719451
17PhosphorylationKGGHGAASPSEKGAH
CCCCCCCCCCCCCCC
28.5530266825
19PhosphorylationGHGAASPSEKGAHPS
CCCCCCCCCCCCCCC
49.8230266825
212-HydroxyisobutyrylationGAASPSEKGAHPSGG
CCCCCCCCCCCCCCC
66.78-
21AcetylationGAASPSEKGAHPSGG
CCCCCCCCCCCCCCC
66.78-
21UbiquitinationGAASPSEKGAHPSGG
CCCCCCCCCCCCCCC
66.78-
26PhosphorylationSEKGAHPSGGADDVA
CCCCCCCCCCCCCCC
39.7429255136
78MalonylationGGGGGGGKSSSSSSA
CCCCCCCCCCCCHHH
50.9026320211
78UbiquitinationGGGGGGGKSSSSSSA
CCCCCCCCCCCCHHH
50.90-
79PhosphorylationGGGGGGKSSSSSSAS
CCCCCCCCCCCHHHH
38.4330576142
80PhosphorylationGGGGGKSSSSSSASA
CCCCCCCCCCHHHHH
37.4121406692
81PhosphorylationGGGGKSSSSSSASAA
CCCCCCCCCHHHHHH
41.1326657352
82PhosphorylationGGGKSSSSSSASAAA
CCCCCCCCHHHHHHH
30.2029978859
83PhosphorylationGGKSSSSSSASAAAA
CCCCCCCHHHHHHHH
31.6929978859
84PhosphorylationGKSSSSSSASAAAAA
CCCCCCHHHHHHHHH
28.3526657352
86PhosphorylationSSSSSSASAAAAAAA
CCCCHHHHHHHHHHH
22.0126657352
95PhosphorylationAAAAAAASSSASCSR
HHHHHHHHCCHHHHH
21.7929978859
96PhosphorylationAAAAAASSSASCSRR
HHHHHHHCCHHHHHH
25.7921406692
97PhosphorylationAAAAASSSASCSRRL
HHHHHHCCHHHHHHH
23.0021406692
99PhosphorylationAAASSSASCSRRLGR
HHHHCCHHHHHHHHH
17.9921406692
100S-nitrosylationAASSSASCSRRLGRA
HHHCCHHHHHHHHHH
3.5222178444
100S-palmitoylationAASSSASCSRRLGRA
HHHCCHHHHHHHHHH
3.5229575903
101PhosphorylationASSSASCSRRLGRAL
HHCCHHHHHHHHHHH
20.2430576142
140PhosphorylationEVQQVRRSHQDFSRQ
HHHHHHHHCHHHHHH
18.2220860994
145PhosphorylationRRSHQDFSRQREELG
HHHCHHHHHHHHHHH
35.4720860994
1822-HydroxyisobutyrylationILRSSQHKQDLTEKA
HHHHCHHHHHHHHHH
37.56-
188UbiquitinationHKQDLTEKAVKQGES
HHHHHHHHHHHHCHH
53.93-
195PhosphorylationKAVKQGESEVSRISE
HHHHHCHHHHHHHHH
50.55-
198PhosphorylationKQGESEVSRISEVLQ
HHCHHHHHHHHHHHH
21.61-
201PhosphorylationESEVSRISEVLQKLQ
HHHHHHHHHHHHHHH
22.1229449344
206UbiquitinationRISEVLQKLQNEILK
HHHHHHHHHHHHHHH
48.13-
2132-HydroxyisobutyrylationKLQNEILKDLSDGIH
HHHHHHHHHHHCCCE
63.38-
213AcetylationKLQNEILKDLSDGIH
HHHHHHHHHHHCCCE
63.3826051181
213UbiquitinationKLQNEILKDLSDGIH
HHHHHHHHHHHCCCE
63.3821890473
213 (in isoform 1)Ubiquitination-63.3821890473
2232-HydroxyisobutyrylationSDGIHVVKDARERDF
HCCCEECCCHHHCCC
44.58-
223AcetylationSDGIHVVKDARERDF
HCCCEECCCHHHCCC
44.5826051181
223MalonylationSDGIHVVKDARERDF
HCCCEECCCHHHCCC
44.5826320211
223UbiquitinationSDGIHVVKDARERDF
HCCCEECCCHHHCCC
44.5821906983
223 (in isoform 1)Ubiquitination-44.5821890473
231PhosphorylationDARERDFTSLENTVE
CHHHCCCCCHHHHHH
36.3729255136
232PhosphorylationARERDFTSLENTVEE
HHHCCCCCHHHHHHH
33.4129255136
236PhosphorylationDFTSLENTVEERLTE
CCCCHHHHHHHHHHH
21.6625850435
247PhosphorylationRLTELTKSINDNIAI
HHHHHHHHHHHCCHH
22.7620446291
256PhosphorylationNDNIAIFTEVQKRSQ
HHCCHHHHHHHHHCH
29.1825599653
260AcetylationAIFTEVQKRSQKEIN
HHHHHHHHHCHHHHH
60.2326051181
2702-HydroxyisobutyrylationQKEINDMKAKVASLE
HHHHHHHHHHHHHHH
48.17-
270AcetylationQKEINDMKAKVASLE
HHHHHHHHHHHHHHH
48.1725825284
2722-HydroxyisobutyrylationEINDMKAKVASLEES
HHHHHHHHHHHHHHC
32.58-
275PhosphorylationDMKAKVASLEESEGN
HHHHHHHHHHHCCCC
39.0229507054
2832-HydroxyisobutyrylationLEESEGNKQDLKALK
HHHCCCCHHHHHHHH
56.92-
283AcetylationLEESEGNKQDLKALK
HHHCCCCHHHHHHHH
56.9226051181
283MalonylationLEESEGNKQDLKALK
HHHCCCCHHHHHHHH
56.9226320211
283UbiquitinationLEESEGNKQDLKALK
HHHCCCCHHHHHHHH
56.92-
283 (in isoform 1)Ubiquitination-56.9221890473
2872-HydroxyisobutyrylationEGNKQDLKALKEAVK
CCCHHHHHHHHHHHH
61.02-
287MalonylationEGNKQDLKALKEAVK
CCCHHHHHHHHHHHH
61.0226320211
287UbiquitinationEGNKQDLKALKEAVK
CCCHHHHHHHHHHHH
61.02-
2902-HydroxyisobutyrylationKQDLKALKEAVKEIQ
HHHHHHHHHHHHHHH
48.78-
294SuccinylationKALKEAVKEIQTSAK
HHHHHHHHHHHHHHH
57.0327452117
3012-HydroxyisobutyrylationKEIQTSAKSREWDME
HHHHHHHHHCCCCHH
50.22-
301UbiquitinationKEIQTSAKSREWDME
HHHHHHHHHCCCCHH
50.22-
312PhosphorylationWDMEALRSTLQTMES
CCHHHHHHHHHHHHH
34.0318669648
313PhosphorylationDMEALRSTLQTMESD
CHHHHHHHHHHHHHH
19.2221712546
316PhosphorylationALRSTLQTMESDIYT
HHHHHHHHHHHHHHH
26.4718669648
322PhosphorylationQTMESDIYTEVRELV
HHHHHHHHHHHHHHH
11.2227259358
323PhosphorylationTMESDIYTEVRELVS
HHHHHHHHHHHHHHH
28.47-
330PhosphorylationTEVRELVSLKQEQQA
HHHHHHHHHHHHHHH
42.3418669648
3322-HydroxyisobutyrylationVRELVSLKQEQQAFK
HHHHHHHHHHHHHHH
44.26-
3552-HydroxyisobutyrylationALQALTEKLLRSEES
HHHHHHHHHHCCHHH
47.81-
355AcetylationALQALTEKLLRSEES
HHHHHHHHHHCCHHH
47.8126051181
355UbiquitinationALQALTEKLLRSEES
HHHHHHHHHHCCHHH
47.8121890473
355 (in isoform 1)Ubiquitination-47.8121890473
362PhosphorylationKLLRSEESVSRLPEE
HHHCCHHHHHHCHHH
22.7226546556
3882-HydroxyisobutyrylationKSDSHGPKEDGGFRH
HHCCCCCCCCCCCCH
73.38-
4052-HydroxyisobutyrylationAFEALQQKSQGLDSR
HHHHHHHHHCCHHHH
31.61-
405AcetylationAFEALQQKSQGLDSR
HHHHHHHHHCCHHHH
31.6126051181
405UbiquitinationAFEALQQKSQGLDSR
HHHHHHHHHCCHHHH
31.61-
422PhosphorylationHVEDGVLSMQVASAR
HHHHCHHHHHCCCHH
12.5520068231
427PhosphorylationVLSMQVASARQTESL
HHHHHCCCHHCHHHH
25.7320068231
431O-linked_GlycosylationQVASARQTESLESLL
HCCCHHCHHHHHHHH
23.22OGP
431PhosphorylationQVASARQTESLESLL
HCCCHHCHHHHHHHH
23.2223532336
436PhosphorylationRQTESLESLLSKSQE
HCHHHHHHHHHCCHH
39.6521712546
440AcetylationSLESLLSKSQEHEQR
HHHHHHHCCHHHHHH
57.0127452117
460PhosphorylationGRLEGLGSSEADQDG
HHHCCCCCCHHHHCC
30.0129255136
461PhosphorylationRLEGLGSSEADQDGL
HHCCCCCCHHHHCCH
34.7029255136
474PhosphorylationGLASTVRSLGETQLV
CHHHHHHHHCCCEEE
36.0725867546
478PhosphorylationTVRSLGETQLVLYGD
HHHHHCCCEEEEECC
25.9625867546
483PhosphorylationGETQLVLYGDVEELK
CCCEEEEECCHHHHH
12.1025867546
490AcetylationYGDVEELKRSVGELP
ECCHHHHHHHHCCCC
46.0026051181
490UbiquitinationYGDVEELKRSVGELP
ECCHHHHHHHHCCCC
46.00-
492PhosphorylationDVEELKRSVGELPST
CHHHHHHHHCCCCHH
32.6520068231
498PhosphorylationRSVGELPSTVESLQK
HHHCCCCHHHHHHHH
58.6825338102
499O-linked_GlycosylationSVGELPSTVESLQKV
HHCCCCHHHHHHHHH
26.76OGP
499PhosphorylationSVGELPSTVESLQKV
HHCCCCHHHHHHHHH
26.7620068231
502PhosphorylationELPSTVESLQKVQEQ
CCCHHHHHHHHHHHH
31.5920068231
512O-linked_GlycosylationKVQEQVHTLLSQDQA
HHHHHHHHHHCHHHH
30.4555826817
515PhosphorylationEQVHTLLSQDQAQAA
HHHHHHHCHHHHHHH
34.5223312004
534PhosphorylationQDFLDRLSSLDNLKA
HHHHHHHHHHHHHHH
29.7422817900
535PhosphorylationDFLDRLSSLDNLKAS
HHHHHHHHHHHHHHH
44.3122817900
5402-HydroxyisobutyrylationLSSLDNLKASVSQVE
HHHHHHHHHHHHHHH
44.89-
540UbiquitinationLSSLDNLKASVSQVE
HHHHHHHHHHHHHHH
44.89-
542O-linked_GlycosylationSLDNLKASVSQVEAD
HHHHHHHHHHHHHHH
22.25OGP
542PhosphorylationSLDNLKASVSQVEAD
HHHHHHHHHHHHHHH
22.2521712546
544PhosphorylationDNLKASVSQVEADLK
HHHHHHHHHHHHHHH
26.4721712546
551TrimethylationSQVEADLKMLRTAVD
HHHHHHHHHHHHHHH
36.11-
551MethylationSQVEADLKMLRTAVD
HHHHHHHHHHHHHHH
36.11-
551UbiquitinationSQVEADLKMLRTAVD
HHHHHHHHHHHHHHH
36.112189047
551 (in isoform 1)Ubiquitination-36.1121890473
555O-linked_GlycosylationADLKMLRTAVDSLVA
HHHHHHHHHHHHHHH
27.37OGP
559PhosphorylationMLRTAVDSLVAYSVK
HHHHHHHHHHHHHEE
20.3928152594
563PhosphorylationAVDSLVAYSVKIETN
HHHHHHHHHEEEECC
13.4028152594
564O-linked_GlycosylationVDSLVAYSVKIETNE
HHHHHHHHEEEECCC
13.75OGP
564PhosphorylationVDSLVAYSVKIETNE
HHHHHHHHEEEECCC
13.7528152594
576PhosphorylationTNENNLESAKGLLDD
CCCCCHHHHHHHHHH
38.1521712546
5782-HydroxyisobutyrylationENNLESAKGLLDDLR
CCCHHHHHHHHHHHH
60.41-
578UbiquitinationENNLESAKGLLDDLR
CCCHHHHHHHHHHHH
60.41-
590MethylationDLRNDLDRLFVKVEK
HHHHHHHHHHHHHHH
37.00-
5942-HydroxyisobutyrylationDLDRLFVKVEKIHEK
HHHHHHHHHHHHHHC
37.02-
594AcetylationDLDRLFVKVEKIHEK
HHHHHHHHHHHHHHC
37.0226051181
5972-HydroxyisobutyrylationRLFVKVEKIHEKV--
HHHHHHHHHHHCC--
52.96-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
232SPhosphorylationKinaseFAM20CQ8IXL6
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
100CPalmitoylation

18296695

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CKAP4_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
HEPC_HUMANHAMPphysical
21988832
TSNAX_HUMANTSNAXphysical
21988832
NDUB7_HUMANNDUFB7physical
21988832
MVP_HUMANMVPphysical
21988832
CKAP4_HUMANCKAP4physical
21988832
THOC7_HUMANTHOC7physical
21988832

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CKAP4_HUMAN

loading...

Related Literatures of Post-Translational Modification
Palmitoylation
ReferencePubMed
"Palmitoylation of cytoskeleton associated protein 4 by DHHC2regulates antiproliferative factor-mediated signaling.";
Planey S.L., Keay S.K., Zhang C.O., Zacharias D.A.;
Mol. Biol. Cell 20:1454-1463(2009).
Cited for: SUBCELLULAR LOCATION, AND PALMITOYLATION AT CYS-100 BY ZDHHC2.
"A reversibly palmitoylated resident protein(p63) of an ER-Golgiintermediate compartment is related to a circulatory shockresuscitation protein.";
Schweizer A., Rohrer J., Jenoe P., De Maio A., Buchman T.G.,Hauri H.-P.;
J. Cell Sci. 104:685-694(1993).
Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 312-326; 413-429 AND491-504, SUBCELLULAR LOCATION, AND PALMITOYLATION.
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312; THR-316 ANDSER-330, AND MASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17, AND MASSSPECTROMETRY.
"Phosphorylation controls CLIMP-63-mediated anchoring of theendoplasmic reticulum to microtubules.";
Vedrenne C., Klopfenstein D.R., Hauri H.P.;
Mol. Biol. Cell 16:1928-1937(2005).
Cited for: FUNCTION IN CYTOSKELETON ANCHORING, AND PHOSPHORYLATION AT SER-3;SER-17 AND SER-19.

TOP